Alaunos Therapeutics | ZIOP - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 6.48B 307M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
Baxter International USD 577M 373M 2025-12
Biogen USD 1.65B 34.6M 2025-12
Bioline Rx USD 343K 111K 2025-09
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Celltrion KRW 626.11B 81.75B 2025-09
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Curis USD 1.14M 8.86M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Incyte USD 1.39B 118.68M 2025-12
Intrexon USD -297K 167K 2024-06
Ionis Pharmaceuticals USD 195M 40M 2025-12
J&J USD 16.6B 118M 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Merck USD 13.42B 431M 2025-09
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Novartis USD 10.25B 570M 2025-12
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Pharma Mar EUR 86.7M 53.34M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Qiagen NV USD 325.27M 19.53M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Sartorius EUR 393.2M 23M 2025-09
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
TG Therapeutics USD 154.43M 20.81M 2025-12
Tilray USD 57.47M 10.16M 2025-06
Verastem USD 14.64M 14.1M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06